Fujita Medical Journal

Instructions to Authors

Aims and Scope

Fujita Medical Journal (FMJ) aims to quickly disseminate and share the latest research in medicine, health science, and related fields and to contribute to the development of both basic and clinical aspects of medicine and health science. The journal publishes original articles, reviews, short reports, case reports, study protocols, cohort profiles, and letters to the editor.

FMJ prioritizes the publication of original research that is scientifically rigorous and ethically sound and does not exclude articles based on apparent significance or interest. The journal is Open Access, and articles are available online to a readership of researchers, clinicians, and other health professionals.

Manuscript Types

The journal welcomes seven manuscript types, all of which are subject to peer review. The following approximate word limits apply (excluding title page and references, but including abstract and figure captions):

The maximum length for each article is 10 printed journal pages, including figures and tables, except for Letters to the editor, which are limited to 2 printed pages.

Original article
Original articles are full and comprehensive reports describing original research.

Review
Reviews present novel or unique overviews of recent or important developments in the field. They must be insightful and must address the question(s) of interest using appropriate and fully presented evidence; exhaustive general summaries will not be published. Reviews are occasionally commissioned by the Editor-in-Chief, and the journal welcomes proposals from interested authors.

Short report
Short reports document original research that has limited or preliminary outcomes.

Case report
Case reports document new findings regarding the diagnosis, treatment, and follow-up of an individual patient.

Study protocol / Cohort profile
Study protocols detail a clinical study, including its objectives/hypotheses, design, data, schedules, and analytical methods. Cohort profiles usually describe the protocols of epidemiological longitudinal cohort studies.

Letter to the editor
The journal welcomes submissions of two types of letters to the editor: opinions on previously published FMJ articles, which must be submitted within 3 months of the original article’s publication date; and reports of preliminary scientific findings.

Journal and Ethics Policies

The journal upholds the highest standards in scholarly publishing.

Before submitting a manuscript to the journal, authors must ensure that they have read and complied with the journal’s policies. The journal reserves the right to reject without review or retract any manuscript that the Editor-in-Chief believes may not comply with these policies.

The responsibilities of the journal’s authors, editors, reviewers, and publisher regarding research and publication ethics are described in full below.

Submission to the journal implies that the manuscript has not been previously published (in any language), is not in press, and is not under consideration for publication elsewhere.

Authors must inform the editors if any related manuscripts are under consideration, in press, or published elsewhere, or if the information within the manuscript has been summarized and published in an Abstract (e.g., conference abstract book). The availability of a manuscript on a publicly accessible preprint server does not constitute prior publication (see ‘Preprints’).

If authors choose to submit their manuscript elsewhere before a final decision has been made on its suitability for publication in the journal, they should first withdraw it from FMJ.

Authors are responsible for complying with best practices in publication ethics, specifically regarding authorship, dual publication, plagiarism, figure manipulation, and competing interests. Submission of a manuscript to the journal implies that all authors have approved it, warrant it is factual, have agreed to its submission, and have the right to publish it.

The journal welcomes manuscript submissions from authors based anywhere in the world.

Originality
The journal follows the policy of the US Department of Health and Human Services Office of Research Integrity (ORI), which defines plagiarism as: “the theft or misappropriation of intellectual property and the substantial unattributed textual copying of another’s work”. The journal also adopts the ORI definition that “the theft or misappropriation of intellectual property includes the unauthorized use of ideas or unique methods obtained by a privileged communication, such as a grant or manuscript review. Substantial unattributed textual copying of another’s work means the unattributed verbatim or nearly verbatim copying of sentences and paragraphs which materially mislead the ordinary reader regarding the contributions of the author.”

The journal uses the Crossref Similarity Check by iThenticate to screen all submissions. Any manuscript with an unacceptable level of unoriginal material may be rejected or retracted at the Editors’ discretion.

Duplicate submission is submitting essentially the same research paper as one that has already been published or submitted to another journal. The editors reserve the right to reject or retract any manuscript that is believed to be a duplicate submission.

Preprints
To support the wide dissemination of research, the journal encourages authors to post their research manuscripts on community-recognized preprint servers, either before or alongside submission to the journal. This policy applies only to the original version of a manuscript that describes primary research. Any version of a manuscript that has been revised in response to reviewers’ comments, accepted for publication, or published in the journal should not be posted on a preprint server. Instead, forward links to the published manuscript may be posted on the preprint server.

Authors should retain copyright in their work when posting to a preprint server.

Scooping
When assessing the novelty of a manuscript submitted to the journal, the editors will not be influenced by other manuscripts that are posted on community-recognized preprint servers after the date of submission to FMJ (or after the date of posting on a preprint server, if the manuscript is submitted to the journal within 3 months).

Authorship
Submission to the journal implies that all authors have seen and approved the author list. Changes to the author list after manuscript submission – such as the insertion or removal of author names or a rearrangement of author order – must be approved by all authors and the editor. No changes to the authorship list or order are allowed after a manuscript is accepted for publication.

Authors are those who contributed substantially to conceiving and designing the study; acquiring the data; analyzing and interpreting the data; performing statistical analysis; handling funding and supervision; providing materials, patients, or resources; drafting the manuscript; making critical revision of the manuscript for important intellectual content; searching relevant literature; or other relevant areas for the manuscript completion. The nature of each author’s contribution should be specified when prompted by the manuscript tracking system during the submission process.

Image integrity
Authors may digitally manipulate or process images, but only if the adjustments are kept to a minimum, are applied to the entire image, meet the relevant community standards, and are clearly described in the manuscript. All images in a manuscript must accurately reflect the original data on which they are based. Authors must not move, remove, add, or enhance individual parts of an image. The editors reserve the right to request original, unprocessed images from the authors. Failure to provide requested images may result in a manuscript being rejected or retracted.

Reproducing copyrighted material
If a manuscript includes material that is not under the authors’ own copyright, the authors must obtain permission from the copyright holder(s) to reproduce it.

If a manuscript includes previously published material, the authors must obtain permission from the copyright owners and the publisher of the original work to reproduce it as relevant to the copyright or licensing status of the work. The authors must cite the original work in their manuscript.

Copies of all reproduction permissions must be included with the manuscript when it is first submitted.

Availability of data and materials
Authors must disclose the source of publicly available data and materials, such as public repositories or commercial manufacturers, by including accession numbers or company details in their manuscript, as appropriate.

Authors may make their own data and materials available by including in their manuscript link(s) to relevant community-recognized public databases or digital repositories. All data sets must be made available in full to the editors and reviewers during the peer review process and must be made publicly available by the date of publication. Authors commit to preserving their data sets for at least 3 years from the date of publication in the journal.

The journal encourages authors to grant reasonable requests from colleagues to share any data, materials, and experimental protocols described in their manuscript.

Animal/human experimentation
Authors of manuscripts describing experiments involving humans or materials derived from humans must demonstrate that the work was carried out in accordance with the principles embodied in the Declaration of Helsinki and any guidelines approved by the authors’ institutions. Where relevant, the authors must include a statement in their manuscript that describes the procedures for obtaining informed consent from participants regarding participation in the research and publication of the research.

Authors of manuscripts describing experiments involving animals or materials derived from animals must demonstrate that the work was carried out in accordance with the guidelines approved by the authors’ institution(s).

Publication of patient information
Written informed consent for publication of personal information of an identifiable living patient (e.g., in case reports) must be obtained from the patient or their parent or guardian as appropriate. If the patient is deceased, consent from the family or guardian is required. Please use the journal’s consent form. The authors must store the signed consent form securely. The Editorial Board has the right to request supporting documentation if necessary, which will be treated confidentially.

Authors are responsible for anonymizing patient data as much as possible. In cases where information is completely anonymized, patient consent may not be required, but the final decision on the need for consent to publish remains with the Editorial Board. Except in cases where it is not necessary to obtain consent from patients or their family, authors must state at an appropriate place within the manuscript text that patient consent has been obtained.

Specimen collection
Manuscripts describing the collection of archaeological, geological, paleontological, or wildlife specimens or samples should include detailed information on their provenance and collection methods. Authors must include a statement in their manuscript describing the relevant ethics guidelines, local laws, and collection permits under which the research was conducted.

Clinical trial registration
The journal recommends that all clinical trials are registered in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. Manuscripts describing clinical trials must include the registration number of the trial and the name of the trial registry.

Reporting guidelines
The journal requires authors to follow the relevant guidelines for health research, such as the STROBE (for observational studies), CONSORT (for randomized controlled trials), and PRISMA statements (for systematic reviews and meta-analyses).

Author competing interests and conflicts of interest
In the interests of transparency, the journal requires all authors to declare any competing or conflicts of interest in relation to their submitted manuscript. A conflict of interest exists when there are actual, perceived, or potential circumstances that could influence an author’s ability to conduct or report research impartially. Potential conflicts include (but are not limited to) competing commercial or financial interests, commercial affiliations, consulting roles, or ownership of stock or equity. A disclosure, or a statement to the effect that the authors have nothing to disclose, should appear at the end of the main text.

Authors should list all funding sources for their work in the Acknowledgments section of their manuscript.

Confidentiality
The journal maintains the confidentiality of all unpublished manuscripts. By submitting their manuscript to the journal, authors warrant that they will keep all correspondence about their manuscript (from the Editorial Office, editors, and reviewers) strictly confidential.

Research misconduct
By submitting a manuscript to the journal, authors warrant that the manuscript and underlying research have not been fabricated, falsified, or plagiarized.

According to the Guidelines for Responding to Misconduct in Research released by the Ministry of Education, Culture, Sports, Science and Technology (2014), fabrication is making up data or research results; falsification is manipulating research materials, equipment, or processes to change data or results obtained from research activities; and plagiarism is appropriating the ideas, analysis, analytical methods, data, research results, research paper(s), or words of other researchers without obtaining the permission of the researchers or giving appropriate credit (see also the ‘Originality’ section).

Self-archiving (Green Open Access) policy
Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. The journal encourages authors of original research manuscripts to upload their article to an institutional or public repository immediately after publication in the journal within the conditions of the article’s CC BY 4.0 license.

Long-term digital archiving
J-STAGE preserves its full digital library, including FMJ, with Portico in a dark archive. In the event that the material becomes unavailable at J-STAGE, it will be released and made available by Portico.

Advertising policy
The journal’s main sources of income are its owner and publication charges. Any commercial considerations have no influence on editorial decision-making. In addition, operations in relation to advertising are handled independently of the Editorial Board.

Peer Review Process

Editorial and peer review process
The journal uses single-blind peer review. When a manuscript is received, it is examined to determine whether its content meets journal requirements. If it does, the manuscript is sent to at least two independent reviewers who are selected by the relevant Associate Editor. Based on the Associate Editor’s considered judgment, the Editor-in-Chief makes the final decision on whether the manuscript is either accepted as submitted, returned for revision, or rejected and returned to the author (via the Editorial Office). A manuscript needing revision will be returned to the author with specific suggestions. The authors should respond by indicating the places where revisions have been made in accordance with the suggestions or by stating their reasons for disagreeing with the suggestions. The revised manuscript should be marked or highlighted to indicate changes.

The Associate Editor then makes a recommendation to the Editor-in-Chief on the manuscript’s suitability for publication and may also make suggestions to the Editor-in-Chief, such as asking the author to change the type of manuscript submitted (e.g., original article, short report, case report, etc.). The Editor-in-Chief is responsible for making the final decision on each manuscript.

The journal considers manuscripts submitted in Japanese; they are peer-reviewed in Japanese and, if accepted, are translated into English by the journal. The English version is checked for consistency with the Japanese version by the Editor-in-Chief and the authors. The accepted Japanese version is appended to the English version online as a supplementary file.

The members of the Editorial Board and International Advisory Board act in advisory roles, providing feedback as reviewers and making suggestions to improve the journal.

Reviewer selection, timing, and suggestions
Reviewers are selected without regard to geography and need not belong to the journal’s Editorial Board. Reviewers are selected based on their expertise in the field, reputation, recommendation by others, and/or previous experience as peer reviewers for the journal.

Reviewers are asked to submit their first review within 3 weeks of accepting the invitation to review. Reviewers who anticipate any delays should inform the Editorial Office as soon as possible.

When submitting a manuscript to the journal, authors may suggest reviewers that they would like included in or excluded from the peer review process. The Associate Editor may consider these suggestions but is under no obligation to follow them. The selection, invitation, and assignment of peer reviewers are at the Associate Editor’s sole discretion.

Reviewer reports
It is the journal’s policy to transmit reviewers’ comments to the authors in their original form. However, the journal reserves the right to edit reviewers’ comments, without consulting the reviewers, if they contain offensive language, confidential information, or other inappropriate material.

Acceptance criteria
Manuscripts are evaluated on their correspondence and adherence to the journal’s Aims and Scope and the various policies outlined within this document. In detail, these include whether the study aims are clearly stated and logical; the rationale/justification for conducting the study is clear; the methods are described in sufficient detail so that the experiment can be reliably reproduced; the study design is robust and appropriate to the stated aims; the conclusions are supported by the data; the discussion is critical and comprehensive; and the references are appropriate in number and up to date.

Furthermore, FMJ prioritizes the following elements in its decision making:

Poor English usage is not a reason for rejection, but if a manuscript’s language is difficult to comprehend, then authors may be asked to revise and resubmit appropriately.

If a manuscript does not meet the journal’s requirements for acceptance or revision, the Editor-in-Chief may recommend rejection.

Editorial independence
The Fujita Medical Society has granted the journal’s Editorial Board complete and sole responsibility for all editorial decisions. The Fujita Medical Society will not become involved in editorial decisions, except in cases of a fundamental breakdown of process.

Editorial decisions are based only on a manuscript’s scientific merit and are kept completely separate from the journal’s other interests.

Appeals
Authors who believe that an editorial decision has been made in error may lodge an appeal with the Editorial Office. Appeals are only considered if the authors provide detailed evidence of a misunderstanding or mistake by a reviewer or editor. Appeals are considered carefully by the Editor-in-Chief, whose decision is final. The guidelines of the Committee on Publication Ethics (COPE) are followed where and when relevant.

Confidentiality in peer review
The journal maintains the confidentiality of all unpublished manuscripts. Editors and reviewers will not:

In addition, reviewers will not reveal their identity to any of the authors of the manuscript or involve anyone else in the review (for example, a post-doc or Ph.D. student) without first requesting permission from the Editor.

Conflicts of interest in peer review
A conflict of interest exists when there are actual, perceived, or potential circumstances that could influence an editor’s ability to act impartially when assessing a manuscript. Such circumstances might include having a personal or professional relationship with an author, working on the same topic or in direct competition with an author, having a financial stake in the work or its publication, or having seen previous versions of the manuscript.

Members of the journal’s Editorial Board and reviewers undertake or are asked to declare any conflicts of interest when handling manuscripts. An editor or reviewer who declares a conflict of interest is unassigned from the manuscript in question and is replaced by a new editor or reviewer.

Editors try to avoid conflicts of interest when inviting reviewers, but it is not always possible to identify potential bias.

Errata and retractions
An Erratum is published when the Editor-in-Chief considers it appropriate to inform the journal readership about an error and to correct it in the published article. The Erratum appears as a new article in the journal, and it cites the original published article.

Retractions are considered and published when there are severe errors in an article that invalidate the conclusions. Retractions are also made in cases where there is evidence of publication malpractice, such as plagiarism, duplicate publication, or unethical research.

In cases of Errata and Retractions, no changes are made to the original article.

An Expression of Concern is considered and published by the Editor-in-Chief as an attachment to the original article if the article is under investigation for severe errors or publication malpractice, or if conflicting opinions exist between the journal’s editors and an institutional investigational board regarding the article’s integrity.

Please address any questions relating to research and publication integrity to the journal’s Editor-in-Chief: igakukai2@fujita-hu.ac.jp

The journal may assign external professionals to adjudicate in complaints that cannot be resolved internally or that are related to the conduct of the journal’s editors.

Editors as authors in the journal
Any member of the journal’s Editorial Board, including the Editor-in-Chief, who is an author of a submitted manuscript is excluded from the peer review process. Within the journal’s online manuscript submission and tracking system, they will be able to see their manuscript as an author but not as an editor, thereby maintaining the confidentiality of peer review.

In cases where the Editor-in-Chief is an author of a manuscript submitted to the journal, an independent Associate Editor is responsible for making the final decision on the manuscript’s suitability for publication in the journal. A manuscript authored by an editor of the journal is subject to the same high standards of peer review and editorial decision making as any manuscript considered by the journal.

Responding to potential ethical breaches
The journal will respond to allegations of ethical breaches by following its own policies and, where possible, the guidelines, standards, and materials of COPE. The journal also follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) on Scientific Misconduct, Expressions of Concern, and Retraction.

The journal takes reasonable steps to identify and prevent the publication of manuscripts where research misconduct has occurred. The journal will never encourage such misconduct or knowingly allow such misconduct to take place.

Copyright, Open Access, and Fees

FMJ is fully Open Access and uses a Creative Commons license on all published works.

Copyright and licensing
Authors retain copyright but are required to sign a License to Publish to grant the Fujita Medical Society permission to reproduce the work in the journal under a Creative Commons Attribution 4.0 (CC BY 4.0) International license after the manuscript is accepted. This license allows anyone to download, reuse, copy, reprint, distribute, or modify articles published in the journal, provided they cite the original authors and source. In such cases, no permission is required from either the authors or the publisher.

Some funding bodies require articles funded by them to be published under a specific Creative Commons license. Before submitting your work to the journal, check with the relevant funding bodies to ensure that you comply with any mandates.

Article Processing Charge
There are many costs associated with publishing Open Access journals, such as those of managing peer review, copy editing, typesetting, and online hosting. The costs are offset by an Article Processing Charge (APC) of 120,000 Japanese yen (including relevant taxes) per manuscript. If both the first and the corresponding authors of a manuscript are members of the Fujita Medical Society, the APC is discounted to 70,000 yen (including relevant taxes) per manuscript. Authors of accepted manuscripts will be invoiced for this fee before publication. There is no submission fee.

Waiver policy
The journal will waive the APC on an article if none of the authors is professionally affiliated with a research organization, or if all authors are from a ‘Least Developed Country’ or ‘Other Low Income Country’ on the OECD’s Development Assistance Committee List of Official Development Assistance Recipients. Other waivers will be considered on a case-by-case basis by the journal’s Editorial Office. Authors must apply for a waiver before or upon the submission of their manuscript; applications will not be considered after the review process has started. Applications may be made by including a request in the cover letter that accompanies the initial submission.

The ability of an author to pay the APC does not influence editorial decisions. To avoid any possibility of undue influence, editors involved with the decision-making process on submitted manuscripts are not involved in any deliberations on waivers.

Manuscript Submission

Manuscripts should be submitted through the journal’s manuscript submission and peer review system. After the Editorial Office has screened the manuscript to ensure the basic requirements are met, it sends an e-mail to all the authors. The e-mail contains a link to the authorship and Conflict of Interest Declaration forms, which must be filled out and returned to the journal via Scholar One. The peer review process cannot start until all authors complete both forms.

If you encounter any problems with online submission, please contact the Editorial Office at the details provided at the end of this document.

Manuscript Preparation

Style
Manuscripts should be prepared in Microsoft Word. The document size should be A4 with page margins of no less than 2.5 cm on each side and 3 cm at the top and bottom. Except for the title page, pages should be numbered in the footer. Line numbers should be inserted on the left side of each page.

English standards
Manuscripts should be written in clear, grammatically correct English. Authors whose native language is not English are strongly encouraged to have their manuscript checked by a native English speaker or by an editing service prior to submission. If a manuscript is not clear due to poor English, it may be returned to the authors before peer review for revision and resubmission as a new manuscript.

Japanese-language manuscript submission
Authors whose native language is Japanese may ask the Editorial Office for permission to submit their manuscript in Japanese. Details about the peer review and translation process for these manuscripts are in the ‘Peer Review Process’ section.

Abbreviations and units
Abbreviations should be defined when first used, in both the abstract and main text, and the abbreviation should be used thereafter. SI or SI-derived units should be used. More information on SI units is available at the Bureau International des Poids et Mesures (BIPM) website.

Cover letter
The cover letter must be included with the first submission of the manuscript. Authors must explicitly state: (a) they are submitting their manuscript to Fujita Medical Journal; (b) the type of the manuscript (i.e., original article, review, short report, case report, study protocol, cohort profile, or letter to the editor); (c) the title of the manuscript; (d) the article’s principal findings and their significance in medicine, health science, or related fields; and (e) a statement indicating that all authors have approved of the submitted manuscript and that its contents have not been published in or submitted to another journal. In addition, any other relevant information, such as applications for APC waivers, other ethics declarations, and so forth, should be included in the cover letter at the time of submission.

Format
Manuscripts should be organized in the following order, with each item beginning on a new page:

1. Title page
2. Abstract and keywords
3. Main text, including competing interests statement
4. Acknowledgments
5. References
6. Figure captions
7. Tables (one per page)
8. Figures (one per page)

Title page
Provide the title, full names of all authors, their degrees (e.g., M.D., Ph.D.) and affiliations, the type of manuscript, a running title (no more than 80 characters including spaces), and the name, address, telephone number, and e-mail address of the corresponding author. Titles should be concise and preferably include terms indexed in literature search databases. Titles should not use abbreviations.

Abstract and keywords
The abstract should be up to 250 words and be followed by up to five keywords. Original articles should use a structured abstract; other article types may do so if appropriate. The structured abstract should comprise the following four sections: Objectives, Methods, Results, and Conclusions. Abstracts and keywords are not required for Letters to the editor manuscripts.

Main text
The main text of original articles should be divided into the following sections in the indicated order: Introduction, Methods, Results, and Discussion (IMRaD style). Other article types should also use similar headings. Subsection headings should be in italics. All figures and tables should be cited in numerical order in the main text. Reference citations should be numbered in their order of appearance in the text and styled using superscript numerals. If applicable, the Methods section should also include information about ethical issues, such as an institution’s review board (ethics review committee) approval of the study proposal or the manner in which informed consent was obtained from study subjects. Letters to the editor manuscripts do not need to follow the IMRaD style.

Acknowledgments
This section should be brief. Authors should list all funding sources for their work in the Acknowledgments section.

References
A list of references should appear after the main text. Use the following reference styles.

Journal article
If there are 16 or more authors, list the first three authors followed by “et al.” Journal names should be abbreviated in accordance with PubMed usage. If an article is cited that has not yet been published, add “(in press)” or “(epub ahead of print)” at the end of the reference entry, as appropriate. Manuscripts under consideration for publication should not be cited.

For articles published in Japanese, insert “(in Japanese)” at the end of the reference entry. If an English version of the article title is not available, please provide the Japanese title in romaji followed by your English translation of the title in parentheses (See below). Do not abbreviate the names of Japanese journals, but indicate the whole title in romaji or use the English name if possible.

All author names. Title of article. Journal name Year; Volume: Pages.

Single-author or multi-author book
Author name(s). Book title. Place of publication: Publisher; Year: Pages cited.

Multi-author book chapter
Author name(s). Chapter title. In: Book title. Edition. Place of publication: Publisher; Year: Pages cited.

Online database
Author name (if no author name is available, please use the name of the organization providing the database). Title of the database; Year. (Date of access).

Tables and figures
Tables
Each table should be placed on a separate page. Tables should be numbered consecutively using Arabic numerals (Table 1, Table 2, etc.). Within tables, column headings should be brief. The title for a table should contain sufficient information for its content to be understood. Any footnotes should be indicated using superscript letters, e.g., a, b.

Figures
The number of figures should be kept to a minimum. Figures should be used only to document experimental results or methods that cannot be properly described in the text. Each figure should appear on a separate page. Figures should be numbered consecutively using Arabic numerals (Figure 1, Figure 2, etc.). Figures using color are acceptable.

After a manuscript has been accepted for publication, figure files must be submitted following the requirements indicated below. However, with the initial submission of a paper, figures can either be included within the Word file or submitted as separate files, provided the editors and reviewers can evaluate them appropriately.

Figure files should be prepared at the desired printed size. Graphs and line figures should be prepared in black and white or RGB mode at a resolution of 900–1200 dpi. For legibility, font sizes smaller than 8-point should not be used. Color photographs should be prepared in RGB mode at a resolution of 300 dpi or higher. Files containing both photographs and lettering should have a resolution of 500 dpi or higher. Hand-drawn figures are not accepted. The above requirements are intended to guarantee print quality and must be followed. The following guideline is a useful reference: http://www.ncbi.nlm.nih.gov/pmc/pub/filespec-images/.

Captions
Figure captions should appear together on a separate page (or pages, in the case of long captions) immediately after the References.

Accepted Manuscripts

Accepted manuscripts are copyedited for style and English by the Editorial Office. Authors may be required to respond to the journal-assigned English copyeditor regarding any corrections. Upon manuscript acceptance, authors are also asked to submit the Consent to Pay Publication Fee Form to the Editorial Office.

Manuscripts that are accepted for publication are copyedited and typeset by the journal’s production team before publication. The journal is published 4 times per year and continuously online as Advanced Online Publications. All communication regarding accepted manuscripts is with the corresponding author.

Proofs

Page proofs are sent to the corresponding author, who should check and return them following the details provided with the proofs. Authors have a single opportunity to proofread their papers. Only corrections due to typesetting errors can be made at this point. Any additional alterations will lead to delays for which authors might be charged.

Contact

To contact the Editorial Office or the Editor-in-Chief, please write to:

Editorial Office, Fujita Medical Journal
c/o Fujita Medical Society
(located in the Fujita Health University Library)
1-98 Dengakugakubo Kutsukake-cho, Toyoake, Aichi 470-1192, Japan
Office: 81-562-93-2425
E-mail: igakukai2@fujita-hu.ac.jp

Updated: 10 January 2023

back to page top